Content Type: Article

  • SEC Charges Novel Insider Trading Case and Shines a Spotlight on ‘Shadow Trading’

    SEC Charges Novel Insider Trading Case and Shines a Spotlight on ‘Shadow Trading’

    ARTICLE / CLIENT ALERT

    SEC Charges Novel Insider Trading Case and Shines a Spotlight on ‘Shadow Trading’

    August 19, 2021

    Read time: 7 min

    Key takeaways
    Overview

    On Aug. 17, 2021, the U.S. Securities and Exchange Commission (“SEC”) filed a complaint against a former corporate executive for “shadow trading,” a form of insider trading where a person uses confidential information about one company to trade in the securities of an “economically linked” company, such as a competitor in the same industry.[1] As further detailed below, the SEC alleged that moments after learning his company was being acquired, a corporate executive purchased the securities of a competing company based on the belief that the competitor’s stock price would rise following the public announcement of the merger.

    While the charges appear to be grounded in existing law, the SEC has never brought a case like this. The defendant is contesting the charges which should create an opportunity for a court to provide clarity as to whether awareness of material, nonpublic information (“MNPI”) about one company precludes trading in an unaffiliated company. In the interim, this enforcement action reveals a new way in which the SEC intends to apply insider trading concepts — one which likely will have significant implications for the entire investment community.

    Background

    The SEC complaint alleges that “within minutes” of learning that Medivation Inc. (“Medivation”) would be acquired by Pfizer Inc., Matthew Panuwat, a senior business development executive at Medivation, purchased out-of-the-money, short-term call options in Medivation’s competitor, Incyte Corporation (“Incyte”).[2] The stock options purchased by Panuwat roughly doubled in value following announcement of the Medivation acquisition, resulting in profits of $107,066.[3] The complaint notes that Panuwat had never before traded in the stock or options of Incyte.[4]

    The SEC’s complaint describes in detail the correlation between the confidential information about the pending acquisition of Medivation and the anticipated positive impact on the stock price of its competitor, Incyte, alleging that Panuwat knew, or was reckless in not knowing, that the information concerning Medivation’s imminent acquisition was not only material to Medivation, but also to Incyte.[5] Specifically, in advance of the announcement, Panuwat reviewed presentations from Medivation’s investment bankers concluding that Medivation and Incyte were similarly situated firms.[6] The complaint notes that Panuwat closely tracked both Incyte and Medivation’s stock prices and knew that a prior M&A announcement by a peer firm the previous year had resulted in material increases to both Incyte’s and Medivation’s stock prices, and therefore Panuwat appreciated the impact that the takeover announcement would have on the competitor’s stock price.[7] The complaint also portrays Panuwat as a sophisticated market participant, in that he had worked in the biopharmaceutical industry for fifteen years, including eight years in the global healthcare investment banking division of a top investment bank.[8]

    As a Medivation employee, the SEC maintains that Panuwat owed Medivation a duty of trust and confidence, including a duty to refrain from using Medivation’s proprietary information for personal gain.[9] In its complaint, the SEC quoted Medivation’s insider trading policy which expressly forbade Panuwat from using Medivation’s confidential information to trade in the securities of any other publicly traded company.[10] Panuwat also did not seek pre-clearance or authorization from Medivation for his options trades and did not inform anyone at Medivation about them after the fact.[11]

    The SEC’s action alleges violations by Panuwat of the anti-fraud provisions of the Securities Exchange Act of 1934, and seeks injunctive relief, civil penalties and a bar from serving as an officer or director of a public company.[12]

    Insider Trading and Shadow Trading

    Under the classical theory of insider trading, a corporate insider violates section 10(b) and Rule 10b-5 by trading in the securities of their own company on the basis of MNPI. The misappropriation theory, by contrast, prohibits corporate outsiders from trading based on MNPI obtained in breach of a duty owed to the source of the information. While the misappropriation theory was controversial when first advanced by the government, it has become well-established by the courts.[13]

    The legality of shadow trading in any particular instance will turn on the question of materiality and the specific facts and circumstances related to the information and the companies at issue, including the scope of the duty owed by the insider to the company. In particular, the SEC will need to establish whether the MNPI was material to the company whose securities were traded. In this case, the specific facts are critical to understand why the SEC brought this action. The complaint emphasizes that the investment banks advising Medivation “drew close parallels between Medivation and Incyte, including that both were valuable, mid-cap, oncology-focused companies with a profitable FDA-approved (commercial stage) drug on the U.S. market.”[14] The SEC also highlighted that Panuwat knew Medivation and Incyte securities traded similarly following a previous merger in the sector and that, although he had never traded Incyte securities previously, Panuwat did so within minutes of learning about the confidential information.[15]

    Implications

    The implications of this case, particularly for private investment funds, are significant. The SEC has staked out new ground that all market professionals should take into consideration and that will continue to define the scope of insider trading in the coming years.

    As with any case of first impression, the SEC has not provided any specific guidance as to what it will consider shadow trading, nor has it defined what it considers economically linked companies. Legal and compliance professionals at private investment funds should pay particular attention to this matter and its impact to their compliance programs, and should consider whether it may be appropriate to update relevant policies and procedures and to provide targeted training. When evaluating whether to restrict trading in a security upon the receipt of MNPI, even if inadvertent, such an analysis should include a determination of whether to restrict trading in “economically linked” companies.

    SRZ anticipates hosting a subsequent event aimed at exploring the implications of this newly filed enforcement proceeding and its impact on the investment community. Please watch for follow-up correspondence as we finalize the details of this important discussion.

    Authored by Craig S. Warkol, Charles J. Clark and Marc E. Elovitz.[16]

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] Complaint, SEC v. Panuwat, No. 4:21-cv-06322 (N.D. Cal. filed Aug. 17, 2021), ECF No. 1, available here; SEC Charges Biopharmaceutical Company Employee with Insider Trading, SEC Press Release No. 2021-155 (Aug. 17, 2021), available here; see also Mihir N. Mehta et al., Shadow Trading, Acct. Rev., July 2021, at 367, manuscript available here.

    [2] Complaint at 8, SEC v. Panuwat, No. 4:21-cv-06322 (N.D. Cal. filed Aug. 17, 2021), ECF No. 1.

    [3] Id. at 8–9.

    [4] Id. at 8.

    [5] Id. at 7.

    [6] Id. at 5.

    [7] Id. at 5–6.

    [8] Id. at 3.

    [9] Id. at 2, 8.

    [10] The policy stated: “During the course of your employment … you may receive important information that is not yet publicly disseminated … about the Company. … Because of your access to this information, you may be in a position to profit financially by buying or selling or in some other way dealing in the Company’s securities… or the securities of another publicly traded company, including all … competitors of the Company. … For anyone to use such information to gain personal benefit … is illegal. …” Id. at 5 (emphasis added).

    [11] Id.

    [12] Id. at 10.

    [13] See United States v. O’Hagan, 521 U.S. 642, 651–53 (1997).

    [14] Complaint at 5, SEC v. Panuwat, No. 4:21-cv-06322 (N.D. Cal. filed Aug. 17, 2021), ECF No. 1.

    [15] Id. at 2, 6, 8.

    [16] This Alert was prepared with the assistance of Derek N. Lacarrubba, Kolby K. Loft and J. Eric Prather.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Marc E. Elovitz

    Partner

    New York – 919 Third Avenue

    More insights

  • OSHA Updates COVID-19 Safety Guidance for All Industries

    OSHA Updates COVID-19 Safety Guidance for All Industries

    ARTICLE / CLIENT ALERT

    OSHA Updates COVID-19 Safety Guidance for All Industries

    August 18, 2021

    Read time: 3 min

    Key takeaways
    Overview

    On August 13, 2021, the US Occupational Safety and Health Administration (OSHA) updated its COVID-19 guidance documents for employers in all industries. The new recommendations echo those published by the US Centers for Disease Control and Prevention (CDC) on July 27, 2021, and build upon OSHA’s healthcare industry requirements.

    In some of its most powerful language yet (and stopping just short of an absolute requirement), OSHA “strongly encourages” employers to provide paid time off to workers for the time it takes for them to get vaccinated and recover from any side effects.

    In depth

    In addition:

    • Employers should consider working with local public health authorities to provide vaccinations for unvaccinated workers in the workplace. Employers should also consider adopting policies that require workers to get vaccinated or to undergo regular COVID-19 testing—in addition to mask wearing and physical distancing—if workers remain unvaccinated.
    • Fully vaccinated workers in areas of substantial or high community transmission should wear masks in order to protect unvaccinated workers.
    • Fully vaccinated workers who have close contact with people with COVID-19 should wear masks for up to 14 days, unless they have a negative COVID-19 test at least three-to-five days after this contact.

    OSHA also described manufacturing; meat, seafood and poultry processing; high-volume retail and grocery; and agricultural processing settings as “higher-risk workplaces.” The agency reorganized some of its COVID-19 guidance materials to clarify the recommendations that apply to these workplaces, including issues surrounding:

    • Carpooling and busing
    • Assembly lines
    • Ventilation in high-density workplaces
    • Customer-facing roles and stockroom roles

    As it has done previously, OSHA continued to emphasize that employee vaccination is the best way to protect employees from COVID-19. OSHA’s top priority appears to remain focused on protecting unvaccinated workers and those who are immunocompromised (regardless of vaccination status).

    OSHA also reaffirmed that it continues to assess the necessity and applicability of the June 21, 2021, Emergency Temporary Standard for healthcare employers.

    We will continue to monitor additional OSHA updates regarding workplace safety and COVID-19. Please visit our Coronavirus Resource Center for up-to-date information.

    Authors

    Abigail M. Kagan

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • The Private Equity Market in Times of Crisis: Rapid Recovery and a Favourable Outlook

    The Private Equity Market in Times of Crisis: Rapid Recovery and a Favourable Outlook

    ARTICLE / CLIENT ALERT

    The Private Equity Market in Times of Crisis: Rapid Recovery and a Favourable Outlook

    August 18, 2021

    Read time: 3 min

    Key takeaways
    Overview

    The COVID-19 pandemic had a major impact on the German M&A landscape in 2020. In mid-March 2020, the market suddenly stagnated. After the lockdown in the second quarter of 2020, however, the private equity market recovered incredibly quickly, despite the omnipresent pandemic.

    Since mid-2020, the number of transactions has increased significantly. According to an analysis by Ernst & Young, the number of private equity transactions in the second half of 2020 amounted to 127, 33 more than in the first six months of the year. Total deal value in 2020 was EUR 34.6 billion, higher than the 2019 total of EUR 32.2 billion. Private equity investors were mainly involved in small and medium-sized transactions. A PwC overview of the top 10 announced deals by foreign investors in German targets clearly shows that private equity transactions dominated in 2020.

    During the COVID-19 pandemic, the information technology sector was particularly important for transactions, followed closely by the industrial sector. The healthcare market also gained prominence. Declines were clearly evident in the automotive sector. Nevertheless, connectivity, autonomous driving and electro mobility continue to be important, irrespective of the pandemic.

    Positive Developments to Be Expected

    Although the pandemic has not yet ended, the private equity market likely will continue to develop positively. The demand for alternative asset classes has increased even more, and a large amount of investment capital is available in the market. Private equity investors usually benefit in crisis years, as they can advance companies on favourable conditions. The persistent low interest rate environment of the central banks is advantageous for private equity investors. Robust deal activity is to be expected particularly in the technology and healthcare sectors. It is also possible that companies under private equity ownership will go public, which promises success due to record share prices.

    It remains to be seen whether the distressed M&A market will increase from 2021. Such a development may be delayed as a result of the temporary suspension of the obligation to file an insolvency application according to the German act to mitigate the consequences of the COVID-19 pandemic.

    International Private Equity Market (IPEM) 2021 | Paris Edition

    We’re delighted to be attending IPEM 2021, where private equity industry professionals will look ahead to how Europe’s economy will build back post-COVID 19.

    In depth
    Authors
    More insights

  • CFTC Steps up Activity in the Cryptocurrency Space with Latest Action for Violations of the Commodity Exchange Act and CFTC Regulations

    CFTC Steps up Activity in the Cryptocurrency Space with Latest Action for Violations of the Commodity Exchange Act and CFTC Regulations

    ARTICLE / CLIENT ALERT

    CFTC Steps up Activity in the Cryptocurrency Space with Latest Action for Violations of the Commodity Exchange Act and CFTC Regulations

    August 11, 2021

    Read time: 6 min

    Key takeaways
    Overview

    On August 10, 2021, the Commodity Futures Trading Commission (CFTC) announced that the US District Court for the Southern District of New York entered a consent order against HDR Global Trading Limited, 100x Holding Limited, ABS Global Trading Limited, Shine Effort Inc Limited and HDR Global Services (Bermuda) Limited (collectively, the BitMEX Entities or BitMEX) and charged each with operating the BitMEX cryptocurrency derivatives trading platform. As a result, market participants should anticipate increased CFTC enforcement within the cryptocurrency space and be mindful of—and comply with—all relevant CFTC rules.

    In depth

    The BitMEX Entities are required to pay a $100 million civil monetary penalty and provides that up to $50 million of the penalty may be offset by payments made by the BitMEX Entities or credited pursuant to a Consent to Assessment of Civil Monetary Penalty entered by the Financial Crimes Enforcement Network (FinCEN). The order also prohibits BitMEX from making further violations of the Commodity Exchange Act (CEA) and the CFTC’s regulations, as charged.

    This order stems from a CFTC action filed on October 1, 2020, against the BitMEX Entities and their three individual founders. The CFTC complaint charged the entities and their founders with operating the BitMEX platform while conducting significant aspects of BitMEX’s business from the United States and unlawfully accepting orders and funds from US customers to trade cryptocurrencies, including Bitcoin, Ether and Litecoin derivatives. BitMEX offered leveraged trading of cryptocurrency derivatives to retail non-eligible contract participants and institutional customers in the United States and throughout the world through its website, mobile application and by direct connection to its trading engine servers via the BitMEX application programming interface (API). Additionally, BitMEX acted as the counterparty to certain transactions on its platform and, more importantly, operated without registering as a designated contract market or a swap execution facility with the CFTC. The order also finds that BitMEX violated the CEA by operating as a Futures Commission Merchant (FCM) without CFTC registration.

    On May 13, 2016, BitMEX launched its first swap product, a “perpetual bitcoin U.S. dollar leveraged swap product.” On its website, BitMEX described its “Perpetual Contract” (or “perpetual swap contract”) as “a product similar to a traditional Futures Contract in how it trades.” BitMEX solicited orders from US-based customers for futures, options and swaps through its website and on social media, which were available to, and accessed by, US-based customers. BitMEX was aware that US customers used virtual private networks (VPNs) to access the BitMEX platform and offered, entered into, confirmed the execution of and otherwise conducted activities relating to commodity option transactions in interstate commerce. These transactions were not executed on any registered board of trade, nor was BitMEX registered as a foreign board of trade.

    BitMEX solicited or accepted orders for the purchase or sale of commodities for future delivery; engaged in soliciting or accepting orders for swaps; engaged in soliciting or accepting orders for retail commodity transactions and/or acted as a counterparty to those transactions. In connection with these activities, BitMEX also accepted money, securities or property—including Bitcoin—to margin, guarantee or secure resulting trades on its platform. (The swaps solicited or accepted by BitMEX included “perpetual swaps” or “perpetual contracts” on Bitcoin, Ether and Litecoin.) BitMEX also operated a trading system or platform in which more than one market participant has the ability to execute or trade swaps on digital assets with more than one other market participant on the system or platform—without registering with the CFTC as a designated contract market or a swap execution facility.

    Additionally, BitMEX failed to implement a customer identification program (CIP), including know-your-customer (KYC) procedures, that would enable it to identify US persons using the BitMEX platform or determine the true identity of the vast majority of its customers. BitMEX also failed to implement an adequate anti-money laundering (AML) program, which is required to prevent or detect, among other things, terrorist financing or other criminal activity, and failed to implement procedures to determine whether a customer appears on lists of known or suspected terrorists or terrorist organizations, such as those issued by the US Department of the Treasury’s Office of Foreign Assets Control (OFAC).

    Acting Chairman of the CFTC Rostin Benham states that, “this case reinforces the expectation that the digital assets industry, as it continues to touch a broader pool of market participants, takes seriously its responsibilities in the regulated financial industry and its duties to develop and adhere to a culture of compliance.” The CFTC is expected to take prompt action when activities impacting its jurisdictional markets raise customer and consumer protection concerns.

    Commissioner of the CFTC Dan Berkovitz stated, “Today’s order enforces our registration, exchange-trading, and anti-money laundering requirements as they apply to cryptocurrency trading. The Commission’s statutory mission also includes promoting ‘responsible innovation and fair competition’ among markets and market participants. Blockchains, smart contracts, and other new technologies have the potential to improve the transparency and efficiency of our derivatives markets. However, for innovation to be responsible and competition to be fair, it must comply with the CEA and our regulations.”

    Market participants should be aware that certain products in the crypto space are commodities or derivatives and are regulated by the CFTC. Much like the US Securities and Exchange Commission (SEC) and FinCEN, the CFTC is likely to increase its enforcement actions in the digital asset space, and market participants need to be mindful of all relevant CFTC regulations.

    Authors

    David L. Taub

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • SEC Approves New Nasdaq Board Diversity Disclosure Rules

    SEC Approves New Nasdaq Board Diversity Disclosure Rules

    ARTICLE / CLIENT ALERT

    SEC Approves New Nasdaq Board Diversity Disclosure Rules

    August 9, 2021

    Read time: 4 min

    Key takeaways
    Overview

    On August 6, 2021, the US Securities and Exchange Commission (SEC) approved a Nasdaq rule change that requires its listed companies to have diverse boards or explain why they do not. Subject to certain issuer exemptions and transition periods, the new rule will require that Nasdaq-listed companies have two diverse directors—including one who identifies as female and another as an underrepresented minority or LGBTQ+—or explain why they do not. Nasdaq-listed companies subject to the rules will also be required to release board-level diversity statistics using a standard template. View the Board Diversity Matrix Instructions and Templates form.

    In depth

    In a written statement, SEC Chair Gary Gensler said the new rules “will allow investors to gain a better understanding of Nasdaq-listed companies’ approach to board diversity, while ensuring that those companies have the flexibility to make decisions that best serve their shareholders.”

    Foreign issuers (including “foreign private issuers”) and “smaller reporting companies” may satisfy the rule by having, or explaining why they do not have, two female directors. Further, each company with a board of directors of five or fewer members may satisfy the rule by having, or explaining why it does not have, one diverse director.

    Nasdaq Global Select Market and Nasdaq Global Market companies will have, or explain why they do not have, one diverse director by the later of August 6, 2023, and two diverse directors by the later August 6, 2025, or the date the company files its proxy or information statement (or, if the company does not file a proxy, in its Form 10-K or 20-F) for the company’s annual shareholder meeting in that year.

    Nasdaq Capital Market companies will have, or explain why they do not have, one diverse director by the later of August 6, 2023, and two diverse directors by the later of August 6, 2026, or the date the company files its proxy or information statement (or, if the company does not file a proxy, in its Form 10-K or 20-F) for the company’s annual shareholder meeting in that year.

    Companies with boards of five or less directors, regardless of listing tier, will have, or explain why they do not have, one diverse director by the later of August 6, 2023, or the date the company files its proxy or information statement (or, if the company does not file a proxy, in its Form 10-K or 20-F) for the company’s annual shareholder meeting in that year.

    After an initial four- or five-year transition period from August 6, 2021, newly listed companies on Nasdaq—including IPOs, direct listings or a company listing in connection with a “de-SPAC” business combination transaction—must meet, or explain why they do not meet, the applicable diversity objectives by the later of two years from the date of listing or the date the company files its proxy statement or its information statement (or, if the company does not file a proxy, in its Form 10-K or 20-F) for the company’s second annual meeting of shareholders subsequent to the company’s listing, with differing milestones depending on the company’s market tier. Companies listing before the expiration of the initial four- or five-year transition period have the remainder of the applicable initial four- or five-year period or two years from the date of listing (whichever is longer) to satisfy the requirement.

    Find additional summary information regarding the new rule, including FAQs, issued by Nasdaq. The full text of Nasdaq’s proposed rule change (with the text of the new rule set forth in Exhibit 5 thereof) and its application for approval to the SEC. Read the SEC’s release approving the new rule.

    For more information, please contact your regular McDermott lawyer or:

    David A. Cifrino | 617-535-4034 | dcifrino@mwe.com

    Thomas P. Conaghan | 202-756-8161 | tconaghan@mwe.com

    Charles Darantiere, a summer associate in the Washington, DC, office, also contributed to this article.

    For more information about McDermott Will & Emery’s diversity, equity and inclusion efforts, please see the Firm’s 2020 D&I Year In Review.

    Authors

    David A. Cifrino

    Counsel

    Boston

    Thomas P. Conaghan

    Partner

    Washington, DC, New York – One Vanderbilt Avenue

    More insights

  • SPAC Litigation Alert: CEO of Acquisition Target Charged in First Criminal Indictment Connected to a De-SPAC Transaction

    SPAC Litigation Alert: CEO of Acquisition Target Charged in First Criminal Indictment Connected to a De-SPAC Transaction

    ARTICLE / CLIENT ALERT

    SPAC Litigation Alert: CEO of Acquisition Target Charged in First Criminal Indictment Connected to a De-SPAC Transaction

    August 9, 2021

    Read time: 8 min

    Key takeaways
    Overview

    After a period of unparalleled growth, Special Purpose Acquisition Companies (“SPACs”) have recently come under significant additional regulatory scrutiny, both with respect to the mechanics of their structure, as well as the subsequent business combination (“de-SPAC”) process.[1] As a result, SPAC initial public offerings (“IPOs”) have dropped significantly from their peak, as market participants continue to process the impact of the evolving regulatory environment.[2] While SPACs will continue to play an important role in providing an alternative method for private companies to access the public markets, the near-term pressure on the SPAC market is likely to continue. A new indictment unsealed by the U.S. Department of Justice (“DOJ”), with a parallel action by the SEC, suggests that criminal authorities are ready to take action if they believe fraudulent conduct is serious enough to merit criminal charges.

    On July 29, 2021, the DOJ unsealed an indictment for securities fraud and wire fraud against Trevor Milton, the founder and former-CEO of the Nikola Corporation (“Nikola”), a green technology vehicle company that went public via merger with a SPAC. While the SEC has been actively scrutinizing SPACs, U.S. v. Milton is the first criminal indictment brought in connection with a de-SPAC transaction.[3] The SEC also filed a civil complaint against Milton on the same day, suggesting that Milton’s conduct was determined to warrant both criminal and civil liability.[4] This follows two weeks after the SEC filed a civil complaint in SEC v. Kokorich, which itself was the second SPAC-related lawsuit filed by the SEC.[5] However, unlike in Kokorich, the DOJ indictment and parallel SEC action against Milton are replete with allegations detailing an intent to defraud investors.[6]

    The charges in Milton arose from a series of allegedly false or misleading statements designed to persuade investors to acquire Nikola securities. The indictment lays out a series of alleged misrepresentations and false statements extending to virtually every part of the nascent green energy startup’s ambitions to produce electric- and hydrogen-powered vehicles, and the fuel and batteries to power them. The lengthy indictment includes details such as Milton allegedly assuring the public that a previously announced vehicle (“Nikola One”) was not “vaporware, i.e., a product that is marketed but does not yet exist,” while it purportedly did not yet have a motor, gears or any type of system that would allow for a driver to direct the vehicle.[7] Nevertheless, the indictment claims that Milton attended the filming of a commercial celebrating innovation in which the Nikola One was repeatedly towed to the top of a hill where its driver released the brakes in order to simulate driving.[8] Further allegations of Milton promoting unsubstantiated claims include Milton allegedly researching the phrase “can you drink water from a fuel cell,” days after allegedly claiming on social media that an electric truck would provide passengers with clean drinking water produced as the hydrogen byproduct from the vehicle’s hydrogen fuel cell.[9]

    The Use of Social Media to Defraud Retail Investors

    In addition to the proliferation of SPACs, social media-driven retail investing has surged over the last year. Social media now provides retail investors with unprecedented access to information about companies interested in availing themselves of the public markets. Regulators have repeatedly expressed concern[10] about the potential for social media-fueled retail investors to become the target of potential fraudsters. These concerns appear to partially underlie the allegations against Milton, as the indictment expressly opines on the importance of SEC rules regarding the IPO “quiet period,” and draws a connection between direct access to retail investors through social media and Milton’s ability to carry out his alleged scheme.

    Specifically, the indictment comparatively frames the IPO and de-SPAC processes, stating that the purpose of the federal securities laws’ mandated IPO quiet period is to create “a level playing field by ensuring that all investors have the same access to information at the same time and to prevent executives from hyping or inflating the stock price … .”[11] By contrast, de-SPAC combinations, which also result in a private company becoming publicly traded, are not subject to quiet period restrictions. The DOJ alleges that Milton used social media to capitalize on the lack of quiet period restrictions, pumping Nikola’s stock price by disseminating numerous false claims directly to retail investors. The SEC similarly focuses on Milton’s use of social media to establish his scienter.

    According to the indictment, Milton’s goal was to “communicate with the market,” and ensure that Nikola had “retail investors on [its] side … to [prevent the stock from being sold short].”[12] To accomplish this, Milton allegedly used various social media outlets such as Twitter and podcasts to disseminate false and misleading statements to retail investors to combat share price declines.[13] Tying Milton’s ability to promote his alleged scheme to the lack of a quiet period for de-SPAC transactions and his use of social media targeted at retail investors, may suggest that the criminal authorities are signaling that deal structures and communication methods are important factors in determining when false and misleading statements in connection with a securities offering rise to the level of criminal fraud. Such a move would also be in line with statements previously made by SEC Chair Gensler, who has specifically questioned the use of projections as part of the de-SPAC process, when their use would normally not be permitted in connection with an IPO.  

    Conclusion

    The allegations in Milton follow a flurry of activity suggesting that SPACs are currently top of mind for regulators. As more regulatory scrutiny and additional criminal actions may follow, SPACs and their sponsors should ensure that their targets are carefully considering representations made to investors. As part of their due diligence, SPAC sponsors should judiciously screen the social media presence of their targets and ensure that target company executives, or promoters, are not disseminating unsupported claims. Finally, when negotiating with targets, SPACs and their sponsors should consider addressing pre-merger public communications by the target, including the timing and methods of delivery. In particular, negotiating strict controls over the timing and content of target-related disclosures may be warranted as one means to permit proper vetting of any public representations.

    This is part of a series of SRZ Alerts regarding SPAC litigation. In addition to our robust SPAC transactions practice, which advises clients on SPAC IPOs and business combination transactions, SPAC sponsor investments, SPAC PIPEs and trading in SPACs generally, SRZ has a SPAC litigation task force advising, monitoring and advocating on SPAC litigation and regulatory developments. If you have any questions, please contact your attorney at Schulte Roth & Zabel or one of the authors.

    Authored by Charles J. Clark, Douglas I. Koff, William H. Gussman, Jr., Ele Klein, Gayle R. Klein, Michael E. Swartz, Derek N. Lacarrubba, J. Eric Prather, Vincent W. Moccio and Hannah Thibideau.


    [1] Please see SRZ’s prior SPAC Litigation Alert for more details, available here. 

    [2] In 2020, SPACs raised more money than in the entire preceding decade — and more in 1Q2021 than all of 2020. Since 1Q2021, there has been a precipitous drop in new SPAC offerings. See, e.g., Kevin Dowd, “‘A Perfect Storm’: Record-Breaking M&A, A SPAC Slowdown, Antitrust Action, Media Mega-Mergers And More From A Frantic First Half Of Deals In 2021,” Forbes, July 4, 2021, available here (last accessed Aug. 2, 2021).

    [3] In addition to the indictment brought against Milton, the existence of at least one other active DOJ investigation into SPAC participants has been disclosed since the start of 2021. See Lordstown Motors Corp., Post-Effective Amendment No. 2 to Form S-1 Registration Statement, 16 (Filed July 15, 2021).

    [4] SEC Charges Founder of Nikola Corp. With Fraud, SEC Press Release No. 2021-141 (July 29, 2021), available here.

    [5] In connection with the complaint filed against Kokorich, the SEC announced a settlement order against the other SPAC participants which, inter alia, contained claims brought under Exchange Act Section 14(a) for failing to conduct adequate due diligence of a target company, allegedly resulting in material misstatements being incorporated into proxy material. Please see SRZ’s prior SPAC Litigation Alert for more details, available here.

    [6] See generally U.S. v. Milton, 23 Crim 478 (S.D.N.Y. 2021).

    [7] U.S. v. Milton, 23 Crim 478 at ¶¶28-30. 

    [8] Id. at ¶35.

    [9] Id. at ¶55.

    [10] See e.g., Securities and Exchange Commission, Office of Investor Education and Advocacy, Celebrity Involvement with SPACs — Investor Alert (March 10, 2021), available here. Note that the SEC has issued similar warnings focused on celebrity promotions associated with cryptocurrency offerings, resulting in enforcement actions being brought against certain celebrity promoters. See e.g., Securities and Exchange Commission, Division of Enforcement and Office of Compliance Inspections and Examinations, SEC Statement Urging Caution Around Celebrity Backed ICOs (Nov. 1, 2017) available here; Two Celebrities Charged With Unlawfully Touting Coin Offerings, SEC Press Release 2018-268 (Nov. 29, 2018), available here.

    [11] Milton, Crim 478 at ¶¶ 9-12. 

    [12] Id. at ¶24.

    [13] See id. at ¶¶ 22-40.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Douglas I. Koff

    Partner

    New York – 919 Third Avenue

    William H. Gussman Jr.

    Partner

    New York – 919 Third Avenue

    Ele Klein

    Partner

    New York – 919 Third Avenue

    J. Eric Prather

    Associate

    New York – 919 Third Avenue

    More insights

  • California Requires Vaccines for Most Healthcare Workers in Healthcare Facilities

    California Requires Vaccines for Most Healthcare Workers in Healthcare Facilities

    ARTICLE / CLIENT ALERT

    California Requires Vaccines for Most Healthcare Workers in Healthcare Facilities

    August 6, 2021

    Read time: 5 min

    Key takeaways
    Overview

    On August 5, 2021, the California Department of Public Health (CDPH) issued a new Order that impacts healthcare employers in California. The CDPH’s Order mandates that almost all healthcare employers require their healthcare workers (and any worker that may be exposed to COVID-19) to be fully vaccinated unless a worker qualifies for a religious or medical exemption. This Order does not invalidate the July 26, 2021, Public Health Order, which remains in effect.

    In depth

    WHAT HEALTHCARE FACILITIES DOES THIS ORDER APPLY TO?

    The Order applies to each of the following facilities:

    • General Acute Care Hospitals
    • Skilled Nursing Facilities (including Subacute Facilities)
    • Intermediate Care Facilities
    • Acute Psychiatric Hospitals
    • Adult Day Health Care Centers
    • Program of All-Inclusive Care for the Elderly (PACE) and PACE Centers
    • Ambulatory Surgery Centers
    • Chemical Dependency Recovery Hospitals
    • Clinics and Doctor Offices (including behavioral health and surgical)
    • Congregate Living Health Facilities
    • Dialysis Centers
    • Hospice Facilities
    • Pediatric Day Health and Respite Care Facilities
    • Residential Substance Use Treatment and Mental Health Treatment Facilities

    WHAT WORKERS DOES THIS APPLY TO?

    The Order applies to all workers who provide services or work in the facilities listed above. In the Order, “worker” is broadly defined to include all paid and unpaid individuals who work in indoor settings where (1) care is provided to patients or (2) patients have access for any purpose.

    This includes (but is not limited to) the following: nurses, nursing assistants, physicians, technicians, therapists, phlebotomists, pharmacists and students and trainees. It also applies to contractual staff not employed by the healthcare facility and persons not directly involved in patient care but who could be exposed to infectious agents that can be transmitted in the healthcare setting (e.g., clerical, dietary, environmental services, laundry, security, engineering and facilities management, administrative, billing and volunteer personnel).

    RELIGIOUS OR MEDICAL EXEMPTIONS 

    The Order exempts workers from the vaccination requirements if a facility receives a declination form, signed by the individual, stating either of the following: (1) the worker is declining vaccination based on religious beliefs or (2) the worker is excused from receiving any COVID-19 vaccine due to qualifying medical reasons.

    To be eligible for a qualified medical reason exemption, the worker must provide to their employer a written statement signed by a physician, nurse practitioner or other licensed medical professional practicing under the license of a physician. The statement should both declare that the individual qualifies for the exemption (but the statement should not describe the underlying medical condition or disability) and indicate the probable duration of the worker’s inability to receive the vaccine (or if the duration is unknown or permanent, so indicate).

    If an operator of a covered facility deems a worker to have met the requirements of a medical or religious exemption, the CDPH’s Order of July 26, 2021, remains in effect, and the unvaccinated exempt worker must meet the following requirements when entering or working in such a facility:

    • Test for COVID-19 with either a polymerase chain reaction (PCR) or an antigen test that either has Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) or be operating per the Laboratory Developed Test (LDT) requirements by the US Centers for Medicare & Medicaid Services (CMS). Testing must occur twice weekly for unvaccinated exempt workers in acute healthcare and long-term care settings; it should occur once weekly for such workers in other healthcare settings.
    • Wear a surgical mask or higher-level respirator approved by the National Institute for Occupational Safety and Health (NIOSH)—such as an N95 filtering facepiece respirator—at all times while in the facility.

    The facility must maintain records of workers’ vaccination, exemption status and COVID-19 testing results consistent with all applicable privacy laws and regulations. The facility must provide these records to the local or state Public Health Officer or their designee promptly upon request, and in any event no later than the next business day after receiving the request.

    These records must be maintained pursuant to the CDPH Guidance for Vaccine Records Guidelines & Standards with the following information: (1) full name and date of birth; (2) vaccine manufacturer; and (3) date of vaccine administration (for first dose and, if applicable, second dose).

    DEADLINE FOR COMPLIANCE

    This Order went into immediate effect on August 5, 2021, at 12:01 am. Facilities must be in full compliance by September 30, 2021.

    Full compliance means all workers who provide services or work in facilities described in the Order must have their first dose of a one-dose regimen (Johnson and Johnson) or their second dose of a two-dose regimen (Moderna or Pfizer-BioNTech) by September 30, 2021, absent a medical or religious exemption.

    The full August 5 Order is found here: https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/Order-of-the-State-Public-Health-Officer-Health-Care-Worker-Vaccine-Requirement.aspx

    Authors

    Yesenia M. Gallegos

    Partner

    Los Angeles

    More insights

  • New Requirements for Employers Using Criminal Background Checks in New York City

    New Requirements for Employers Using Criminal Background Checks in New York City

    ARTICLE / CLIENT ALERT

    New Requirements for Employers Using Criminal Background Checks in New York City

    August 6, 2021

    Read time: 9 min

    Key takeaways
    Overview

    The New York City Commission on Human Rights (“Commission”) released its updated Legal Enforcement Guidance on the Fair Chance Act and Employment Discrimination on the Basis of Criminal History, which interprets the amendments to the New York City Fair Chance Act (“FCA”) that went into effect on July 29, 2021. We have previously written on the FCA’s ban on performing criminal background checks on applicants prior to a conditional offer of employment. The amendments provide additional employment protections to applicants and employees with a criminal history, pending criminal arrest or charges, or certain “non-convictions.”

    A Conditional Offer Should Only Be Made After All Other Checks Are Done

    The FCA prohibits employers from asking about or considering information about an applicant’s conviction history or pending criminal cases until after the employer has assessed all other job qualifications and made a conditional offer of employment to the applicant. According to the new Guidance, employers who wish to withdraw a conditional offer based on the applicant’s criminal history can only withdraw the offer based on:

    1. The results of a criminal background check conducted in accordance with the Fair Chance Process (discussed below);
    2. The results of a medical exam in situations in which such exams are permitted by the Americans with Disabilities Act; or
    3. Other information the employer could not have reasonably known before the conditional offer if the employer can show as an affirmative defense that, based on the information, it would not have made the offer regardless of the results of the criminal background check.

    Employers, therefore, are required to institute a two-tiered background check process. They should perform all non-criminal background checks (e.g., checking references, confirming prior employment, verification of educational degrees, etc.) on prospective employees before the conditional offer of employment. These background checks must still comply with other relevant laws, such as the Fair Credit Reporting Act (as discussed in this Alert). Accordingly, consumer reporting agencies must issue separate non-criminal and criminal background check reports, or employers must institute a system to internally segregate such records to ensure that decision makers cannot access the criminal history until after a conditional job offer has been extended.[1]

    Non-Convictions Cannot Be Considered

    The amendments to the FCA make it illegal for an employer to consider non-convictions, including convictions for violations (such as trespass or disorderly conduct) or non-criminal offenses, instances when the police decided not to charge or prosecute following arrest, and criminal charges resolved in the favor of the individual, including adjournments in contemplation of dismissal, convictions that were sealed, etc. Non-convictions are “completely protected.” Post offer of employment, employers should consider using the following suggested language set forth in the new Guidance to avoid unlawful inquiries about non-convictions:

    Have you ever been convicted of a misdemeanor or felony? Answer “NO” if you received an adjournment in contemplation of dismissal (“ACD”) that has not been revoked and restored to the calendar for further prosecution or if your conviction: (a) was sealed, expunged, or reversed on appeal; (b) was for a violation, infraction, or other petty offense such as “disorderly conduct;” (c) resulted in a youthful offender or juvenile delinquency finding; or (d) if you withdrew your plea after completing a court program and were not convicted of a misdemeanor or felony.

    The NYC Fair Chance Process

    The amendments to the FCA also make it illegal to refuse to hire an applicant or take adverse action against a current employee on the basis of a pending criminal charge (i.e., a pending arrest) without performing the “Fair Chance Process.” The Fair Chance Process requires employers to perform a “Fair Chance Analysis” by considering “the relevant Fair Chance Factors” prior to making a decision to deny employment. With respect to arrests or convictions preceding the application for employment, “the relevant Fair Chance Factors” refers to the New York State mandated Article 23-A factors, discussed in our prior Alert. With respect to arrests or criminal accusations pending at the time of an application for employment, or during employment, “the relevant Fair Chance Factors” means the following “NYC Fair Chance Factors”[2]:

    1. The policy of New York City to overcome stigma toward and unnecessary exclusion from employment of persons with criminal justice involvement;
    2. The specific duties and responsibilities necessarily related to the employment held by the person;
    3. The bearing, if any, of the criminal offense or offenses for which the applicant or employee was convicted, or that are alleged in the case of pending arrests or criminal accusations, on the applicant or employee’s fitness or ability to perform one or more such duties or responsibilities;
    4. Whether the person was 25 years of age or younger at the time of occurrence of the criminal offense or offenses for which the person was convicted, or that are alleged in the case of pending arrests or criminal accusations, which shall serve as a mitigating factor;
    5. The seriousness of such offense or offenses;
    6. The legitimate interest of the employer in protecting property and the safety and welfare of specific individuals or the general public; and
    7. Any additional information produced by the applicant or employee, or produced on their behalf, in regards to their rehabilitation or good conduct, including, but not limited to, history of positive performance and conduct on the job or in the community.

    At the conclusion of the employer’s individual assessment of the applicant’s or employee’s criminal history after applying the Article 23-A or NYC Fair Chance Factors, the employer must follow the modified four-step Fair Chance Process:

    1. Disclose to the applicant or employee a written copy of the inquiry the employer conducted;
    2. Request from the applicant or employee any information that will be relevant to the employer’s analysis;
    3. Disclose to the applicant or employee a written copy of the employer’s analysis under the relevant Fair Chance Factors; and
    4. Provide at least five business days for the applicant or employee to respond to the employer’s decision, during which time the employer must hold the applicant’s or employee’s job open.

    Enhanced Protections for Applicants and Employees

    The amendments to the FCA add additional protections for applicants and employees. An employer that wishes to deny employment to an applicant or to discipline or terminate an employee on the basis of criminal conviction history or a pending criminal case must follow the Fair Chance Process, including consideration of the relevant Fair Chance Factors. The employer may deny employment to the applicant or discipline or terminate an employee on the basis of criminal conviction history or a pending criminal case if, after conducting a Fair Chance Analysis, the employer properly:

    1. Determines that there is a direct relationship between the alleged or convicted conduct and the job; or
    2. Shows that employment “would involve an unreasonable risk to property or to the safety or welfare of specific individuals or the general public.”

    An employer is permitted to place an employee on leave for a reasonable period of time while it conducts the Fair Chance Analysis. If the employee has accrued leave time, the employee should be permitted to use that time consistent with the employer’s policies on leave.

    Changes to the Definition of Applicant

    The definition of “applicant” now includes current employees who are seeking or being considered for promotion or transfer, in addition to persons seeking initial employment. Conditional offers of employment therefore include offers of promotion or transfer of current employees. Employers may only revoke such conditional offers of employment based on the limited exceptions enumerated above.

    Exemptions to the Amendments to the Fair Chance Law

    Certain employers are exempt from some or all portions of the changes to the Fair Chance Law described above. To the extent that the FCA conflicts with financial industry-specific rules and regulations promulgated by a self-regulatory organizations, financial industry employers do not need to comply with the FCA.

    Likewise, federal, state or local laws may require an employer to perform a criminal background check on an applicant prior to extending even a conditional offer of employment. In such cases, employers may advise applicants once they apply for the position that a background check is required and will be conducted prior to a conditional offer of employment. The employer may conduct the criminal background check before extending the conditional offer in that case, but must still conduct a Fair Chance Analysis of the applicant’s criminal history and provide the applicant with a copy of the inquiry and Fair Chance Notice and provide a reasonable period of at least five days to respond to the employer’s concerns.

    Conclusion

    These amendments enhance job protections to applicants with criminal histories, and provide protection to current employees. Employers must review their hiring process, background check procedures and other policies to ensure compliance with the FCA.

    Authored by Mark E. Brossman, Ronald E. Richman and Scott A. Gold.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] The Commission encourages employees to avoid using the term “background check,” and instead use terms like “consumer report” or “investigative consumer report” in any authorization notice used prior to a conditional offer. Note that driving records may contain both criminal and non-criminal information and should not be reviewed until after a conditional offer.

    [2] If an applicant has both a conviction history and a pending criminal charge, the employer must separately analyze each according to the relevant Fair Chance Factors.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Mark E. Brossman

    Partner

    New York – 919 Third Avenue

    Ronald E. Richman

    Partner

    New York – 919 Third Avenue

    More insights

  • Antitrust M&A Snapshot | Q2 2021

    Antitrust M&A Snapshot | Q2 2021

    ARTICLE / REPORT

    Antitrust M&A Snapshot | Q2 2021

    August 5, 2021

    Read time: 15 min

    Overview

    APRIL – JUNE 2021: HIGHLIGHTS

    UNTIED STATES:

    • The premerger notification landscape continues to shift as filings reach another record high, and the US Congress contemplates increases to filing fees and New York State contemplates its own premerger notification regime.
    • Technology companies remain in the “hot seat” as legislators in the US House of Representatives (House) introduced five antitrust reform bills that would change the enforcement landscape for digital platforms, including seeking to preclude large digital platform companies from acquiring smaller, nascent competitors.
    • Aggressive antitrust enforcement is likely to continue with the appointment of Lina Khan as Federal Trade Commission (FTC) Chair and the nomination of Jonathan Kanter to lead the Department of Justice’s (DOJ) Antitrust Division. This appointment reemphasizes the Biden administration’s commitment to more stringent antitrust regulation just as Congress appears to be close to increasing the budgets of both the FTC and DOJ.
    • The DOJ is making good on President Biden’s pledge to regulate “Big Ag” by challenging Zen-Noh Grain Corporation’s proposed acquisition of 38 grain elevators from Bunge North America, Inc.

    EUROPEAN UNION:

    • In Q1 2021, the European Commission (Commission) published its Guidance on Article 22 of the EU Merger Regulation (EUMR). The Guidance encourages the EU Member States to refer certain transactions to the Commission even if the transaction is not notifiable under the laws of the referring Member State(s). In Q2, not long after the issuance of the Guidance, the Commission received its first referral request to assess the proposed acquisition of GRAIL by Illumina.
    • In light of the growing global debate on the need for more effective merger control, EU Competition Commissioner Margrethe Vestager confirmed that the Commission will not soften EU merger policy going forward. The Commission’s statement was made despite the fact no deals have been blocked by the Commission in about the last two years. It should be noted, however, that in April 2021, Air Canada abandoned its proposed acquisition of Transat after the Commission raised serious competition concerns.
    • On May 5, 2021, the Commission proposed a Regulation on foreign subsidies that potentially distort the EU internal market. The proposed Regulation introduces three tools, two of which would have an impact on M&A transactions. One tool concerns a mandatory notification mechanism whereby the Commission would investigate M&A deals meeting a certain threshold. Another tool concerns a general market investigation tool for investigating smaller transactions that do not trigger the thresholds under the mandatory notification mechanism.

    UNITED KINGDOM:

    • From April 7 to May 5, 2021, the Competition and Markets Authority (CMA) held a consultation on revised guidance regarding interim measures in merger investigations and a new draft of its template initial enforcement order for use in completed cases.
    • On April 20, 2021, the CMA issued a joint statement with the German and Australian competition authorities on the need for rigorous and effective merger enforcement. In particular, the three competition authorities stress that a policy of requiring structural remedies over behavioral remedies should be pursued with a view to alleviating identified competition concerns.
    • The CMA is working on revised guidance on financial penalties in merger cases. According to the CMA, the CMA’s current fining powers are insufficient to ensure compliance and should be reinforced, especially when compared with the powers of the European Commission.
    In depth

    KEY THEMES AND TAKEAWAYS

    UNITED STATES

    • Premerger Notification Landscape on the Verge of Dramatic Change Amid Record Number of Filings

    In May, Hart-Scott-Rodino (HSR) filings reached a new monthly high for 2021 with 326 filings. This surpassed the previous monthly high for the year of 323 filings in March 2021. In April and May alone there were 592 filings, signalling that there will likely be no slowing down for mergers and acquisitions following a busy first quarter.

    These filings may soon carry significantly higher filing fees, as the US Senate passed the Merger Filing Fee Modernization Act of 2021 on June 6, 2021. The bill amends 15 U.S.C. § 18(a) and significantly increases filing fees for high-value mergers. The largest fee increase being for mergers of $5 billion or more, where the fee will increase from $280,000 to $2,250,000. The US House has introduced a similar version of the bill.

    New York State is on the precipice of creating its own premerger notification regime after the New York State Senate passed the Twenty-First Century Anti-Trust Act, by a vote of 43-20, on June 7, 2021. The bill must now pass the New York State Assembly. The premerger notification provision would be the first at the state level and its scope would capture smaller deals than those reportable under the federal premerger notification regime. Under the proposed bill, transactions that result in the acquirer holding more than $8 million in assets or voting securities of the target would need to be notified.

    • US House Addresses Perceived History of Shortcomings in Digital Platform Acquisitions

    On June 11, 2021, the US House introduced five antitrust reform bills. One such bill, the Platform Competition and Opportunity Act, would preclude any digital platform company from merging with or acquiring a company that competes in any overlapping service or product with the digital platform.

    The bill explicitly exempts acquisitions where the target does not constitute a nascent or potential competitor to the covered platform. The bill appears to be a direct response to the government’s concerns about alleged harm to competition following prior approval of nascent competitor acquisitions, particularly in Big Tech.

    On June 23, 2021, this bill was approved by the US House Judiciary Committee with a 24-to-17 vote and now faces a floor vote by the entire US House.

    • Lina Khan and Jonathan Kanter Tapped to Lead Antitrust Agencies, Likely Leading to Increased Enforcement

    On June 15, 2021, Lina Khan was confirmed by the US Senate as an FTC Commissioner. In an unexpected move, she was also immediately appointed as FTC Chair, becoming the youngest Chair in the Commission’s history. Khan’s appointment likely signals increased scrutiny of mergers and acquisitions and expanded FTC enforcement for deals involving non-traditional theories of harm.

    Khan has advocated for blocking mergers as a way to protect labor markets from lower compensation and workforce reductions. On July 1, 2021, Khan and the new Democratic majority of commissioners voted 3-to-2 to revoke the 2015 Policy Statement providing that the Commission would adhere to the consumer welfare standard in determining which cases to pursue. Revoking this statement is the first step in expanding the scope of FTC’s powers pursuant to Section 5 of the FTC Act. Khan has also been an outspoken critic of behavioral remedies and may have an increased willingness to litigate against merging parties.

    Under Khan, the FTC also recently voted to repeal a long-standing policy that had eliminated “prior approval” obligations for future transactions in FTC consent orders. The FTC appears poised to insist on such provisions in future merger settlements, providing it with significantly greater authority to review and block future transactions of companies subject to these settlements. Parties should take this change into account when negotiating antitrust risk provisions in transaction agreements going forward.

    On July 20, 2021, President Biden nominated Jonathan Kanter to serve as Assistant Attorney General for the DOJ’s Antitrust Division. Like Khan, Kanter is an outspoken critic of Big Tech, having represented complainants before antitrust enforcers against many prominent technology companies. Kanter has yet to be confirmed by the US Senate.

    Khan and Kanter may soon have additional resources at their disposal, as the Merger Filing Fee Modernization Act of 2021 would increase the budgets of the FTC and DOJ to $252 million and $418 million, respectively. Additionally, the White House has asked Congress to increase the respective budgets of the FTC’s Bureau of Competition and the DOJ’s Antitrust Division by about 17% and 6% for the next fiscal year. The FTC has indicated it plans to use the increased funding, if approved, to expand its full-time staff and hire outside economic experts.

    • DOJ Takes First Step in President Biden’s Mission to Regulate “Big Ag”

    On June 1, 2021, the DOJ announced that Zen-Noh Grain Corp. must divest nine grain elevators across nine geographic markets in order to consummate its proposed $300 million acquisition of 48 grain elevators from Bunge North America.

    Zen-Noh Grain Corp. is the US subsidiary of the National Federation of Agriculture Cooperative Associations of Japan and trades in corn, soybeans, sorghum, wheat and by-products. Bunge North America is engaged in grain origination, grain processing and grain trading.

    This DOJ challenge aligns with the Biden administration’s pledge to address market concentration in “Big Ag.” Tim Wu, a member of the National Economic Council, had previously called for a retrospective investigation into whether the DOJ was right in its decision to approve agriculture mergers that had consolidated the industry in the mid-2000s. This action by the DOJ could serve as a bellwether for future regulatory action in the agriculture industry.

    EUROPEAN UNION

    • Recent Guidance on Article 22 EUMR Put into Practice with the Referral of Illumina / GRAIL

    Following the publication of the Commission’s Guidance on Article 22 EUMR on March 26, 2021, the Commission swiftly accepted its first referral request on April 19, 2021. France submitted an initial referral request to the Commission regarding Illumina’s proposed acquisition of GRAIL. Belgium, Greece, Iceland, the Netherlands and Norway soon followed suit and joined France’s referral request.

    Illumina is a US-based global genomics company and a leading supplier of next-generation sequencing systems for genetic and genomic analysis. GRAIL is also a US-based company and develops cancer detection tests relying on next-generation sequencing systems. The proposed acquisition did not reach the EU notification thresholds and was not notifiable in any Member State.

    On April 19, 2021, the Commission accepted the referral request on the basis that the combined entity could restrict access to, or increase prices of, next-generation sequencers and reagents to the detriment of GRAIL’s rivals active in genomic cancer tests. In particular, the Commission considered that a referral of the transaction was appropriate because GRAIL’s competitive significance is not reflected in its turnover despite the fact that the deal is valued at $7.1 billion.

    The Commission’s review is arguably controversial because the transaction does not meet the thresholds for notification to the Commission or any EU Member State. In light of this, Illumina has sought an annulment of the Commission’s decision to review the transaction before the General Court. The case is still pending.

    • Merger Enforcement Remains High Despite COVID-19; Third Phase II Merger Withdrawal in Two Years

    At the European Competition Day, EU Competition Commissioner Margrethe Vestager stated that EU merger policy has not become less stringent vis-à-vis dealmakers, despite the fact that no deals have been vetoed for over two years. Ms. Vestager pointed to three mergers that were abandoned over the past two years after the Commission raised competition concerns. Most recently, Air Canada withdrew its proposed acquisition of Transat (see below, Notable European & UK Cases). During the first quarter of 2021, Fincantieri also abandoned its proposed acquisition of Chantiers de l’Atlantique, and in 2020, Johnson & Johnson withdrew its proposed takeover of TachoSil. Ms. Vestager’s comments are particularly meaningful in light of the growing global debate on the need for more effective merger control.

    Ms. Vestager noted that the EU merger rules have not been relaxed in light of the COVID-19 pandemic. Especially with regard to the Air Canada’s abandoned acquisition of Transat, Ms. Vestager stated, “When applying merger control during severe shocks, we need to make sure that as companies emerge from the crisis, the competitive foundations are still there for the industry to take off again.”

    In addition, the Commission continues to investigate companies for allegedly failing to provide information during merger investigations. In May 2021, the Commission issued a €7.5 million fine to an entity it alleged committed three infringements of the EUMR by allegedly providing deliberately, or at least negligently, incorrect or misleading information during discussions of a remedies package. Since the EUMR took effect in 2004, the Commission has adopted just two other such decisions. In 2017, the Commission fined Facebook €110 million for allegedly providing incorrect or misleading information during the investigation of its acquisition of WhatsApp. In 2019, the Commission fined General Electric €52 million for allegedly providing incorrect information during the investigation of its acquisition of LM Wind.

    • Commission Proposes New Regulation on Foreign Subsidies that Potentially Distort the EU Internal Market

    On May 5, 2021, the Commission proposed a new Regulation on foreign subsidies that potentially distort the internal market. The proposed regulation provides for new mechanisms, running alongside the EU merger control rules, which would enable the Commission to address the potential distortive effects of foreign subsidies in the EU internal market. The Commission has proposed two investigation tools that would have an impact on M&A transactions in particular.

    First, under the proposed regime, the Commission would be able to review transactions involving a financial contribution by a non-EU government, where the EU turnover of the company to be acquired (or of at least one of the merging parties) is €500 million or more, and the foreign financial contribution is at least €50 million. If the transaction at hand meets these thresholds, the acquirer would need to notify any financial contribution received from a non-EU government before the deal in question can be closed.

    Second, the Commission also foresees having at its disposal a general tool, which can be applied to smaller deals falling below the thresholds for mandatory notification. The Commission would be able to investigate the transaction in question on its own initiative and may request ad hoc notifications. In such cases, the Commission would be able to take into account foreign subsidies granted in the 10 years prior to launching its ex officio investigation.

    UNITED KINGDOM

    • CMA Holds Public Consultation on Guidance on Interim Measures in Merger Cases

    Between April 7 and May 5, 2021, the CMA held a public consultation with a view to seeking views on its revised guidance on interim measures, i.e., measures taken by the CMA to prevent or unwind preemptive action in merger cases, and its revised initial enforcement order template. The CMA noted that it has become increasingly aware of merging parties taking insufficient steps to ensure compliance with interim measures. Therefore, the aim of the draft revised guidance is to provide further clarification in relation to whom interim measures will apply.

    The draft revised guidance reflects the CMA’s expectations on the steps that merging parties should take to ensure compliance with interim measures. In particular, “the merging parties should take a risk-based approach to the design and implementation of any steps taken to ensure compliance with interim measures.” In this regard, the CMA considers that the following steps are, as a minimum, likely to be necessary to ensure compliance: (i) tailored guidance and staff training; (ii) internal communications reiterating the importance of compliance; (iii) governance structures to oversee compliance; (iv) where appropriate, delegations of authority; and (v) ongoing oversight and reporting mechanisms.

    • CMA Issues Joint Statement on Need for Rigorous and Effective Merger Enforcement

    On April 20, 2021, the CMA issued a joint statement along with German and Australian competition authorities on the need for rigorous and effective merger enforcement. The competition authorities made this statement in light of the high levels of concentration being seen across various markets in the UK, Germany and Australia, as well as in light of an increase in the number of merger reviews involving dynamic and fast-paced markets. Moreover, the competition authorities consider that effective merger control remains important in circumstances where the economy has been weakened, including in light of the COVID-19 pandemic.

    With respect to dynamic and fast-paced markets, the competition authorities stress that anticompetitive mergers in these markets can cause significant harm, given the increased importance of products and services in this area and the aggregation of data over time across various services. According to the competition authorities, technology markets can be highly concentrated with high barriers to entry due to network effects, allegedly resulting in market power for many years.

    The competition authorities also note that structural remedies should be favored over behavioral remedies. According to the authorities, behavioral remedies have many disadvantages: they can create continuing economic links and dependencies unlikely to recreate the intensity of premerger competition on the market; raise risks of circumvention; become outdated in light of changed market conditions; distort the natural development of the market; and are more burdensome because of the need for post-merger monitoring. On the other hand, structural remedies are more likely to preserve competition and lead to an optimal solution for stakeholders and are therefore, according to the competition authorities, in the best interests of consumers.

    • CMA Revising Guidance on Financial Penalties

    The CMA’s Non-Executive Director and Chair, Jonathan Scott, recently stated that the CMA is working on revised guidance on financial penalties in merger cases.

    Scott noted that the CMA’s current fining powers are insufficient and need to be strengthened to ensure compliance. For example, in a recent case, the CMA fined an acquirer £55,000 for failing to provide information in a timely manner during a merger investigation. The Commission, on the other hand, was able to impose a fine of €110 million on Facebook for providing incorrect or misleading information during the investigation of its acquisition of WhatsApp. According to Mr. Scott, this example shows that the CMA’s fining powers need to be bolstered.

    It is expected that the CMA will launch a public consultation on the revised guidance on financial penalties in Q3 2021.

    Tabs

    Graham J. Hyman

    Associate

    New York – One Vanderbilt Avenue

    Jon B. Dubrow

    Partner

    Washington, DC

    Joel R. Grosberg

    Partner

    Washington, DC

    Lisa P. Rumin

    Partner

    Washington, DC

    More insights
    Endnotes

  • Infrastructure Bill Provision Expands Cryptocurrency Reporting Requirements

    Infrastructure Bill Provision Expands Cryptocurrency Reporting Requirements

    ARTICLE / CLIENT ALERT

    Infrastructure Bill Provision Expands Cryptocurrency Reporting Requirements

    August 5, 2021

    Read time: 6 min

    Key takeaways
    Overview

    On August 1, 2021, the US Senate unveiled the draft text of the Infrastructure Investment and Jobs Act (Bill), a highly anticipated $1 trillion infrastructure package negotiated by the White House and a bipartisan group of senators. As discussed below, the Bill includes a provision (Section 80603) that, if enacted in its current form, would amend the Internal Revenue Code (Code) to extend certain reporting requirements for transactions involving digital assets, including cryptocurrencies such as Bitcoin and Ether and other forms of digital tokens. The provision, which would generally go into effect on January 1, 2023, is intended to address a “tax gap” resulting from the underreporting of cryptocurrency transactions.

    In depth

    BROKER REPORTING

    Code Section 6045 generally imposes reporting requirements on “every person doing business as a broker” with respect to sales affected by the broker on behalf of its clients. Under current law, such reporting is currently limited to sales of corporate stock, interests in trusts and partnerships, debt obligations, certain commodities and various associated derivatives. Pursuant to regulations, such sales are reported by the broker on Form 1099-B and the information required to be reported includes identifying information about the taxpayer and the property sold, the sale date and gross proceeds of the sale—and only with respect to the sale of a “covered security,” the adjusted basis of the property sold and the character of the gain or loss on the sale (i.e., long- or short-term capital gain).

    For purposes of 1099-B reporting, a “broker” is defined to include a “dealer, a barter exchange, and any other person who (for a consideration) regularly acts as a middleman with respect to property or services.” A typical example of a broker subject to 1099-B reporting is a brokerage firm that facilitates transactions for customers in stocks, bonds and/or commodities.

    The Bill expands the definition of a broker to include “any person who (for consideration) is responsible for regularly providing any service effectuating transfers of digital assets on behalf of another person.” Unless otherwise provided by the US Department of the Treasury’s regulations, a “digital asset” means “any digital representation of value which is recorded on a cryptographically secured distributed ledger or any similar technology as specified by [Treasury].” A cryptocurrency exchange would be considered a broker under this language.

    The “basis” reporting under Section 6045 only applies to “covered securities.” Under current law, the term covered securities generally includes corporate stock shares, debt obligations, certain designated commodities (and derivatives thereof) and other financial instruments. The Bill would expand the definition of covered securities to include any “digital asset.” Accordingly, brokers subject to Section 6045 will be required to report the adjusted basis and the character of the gain or loss upon the sale of digital assets, including utility tokens, stablecoins and asset-backed tokens.

    BROKER-TO-BROKER AND BROKER-TO-NON-BROKER TRANSFER REPORTING

    Under current law, Code Section 6045A imposes additional reporting requirements that are generally applicable to the transfer of covered securities by one broker to another. Specifically, the transferor broker must provide a statement setting forth certain information (specified within regulations) about the covered securities transferred so that the transferee broker is able to comply with the 1099-B reporting requirements upon a subsequent sale of the transferred securities. By including digital assets within the definition of covered securities, the Bill imposes this transfer statement reporting requirement on the broker-to-broker transfer of digital assets.

    The Bill also expands Section 6045A by imposing an additional reporting requirement when a broker transfers a covered security that is a digital asset to “an account which is not maintained by, or an address not associated with, a person that such broker knows or has reason to know is also a broker” (i.e., a non-broker). In this situation, the transferor must make an information return with the Internal Revenue Service (IRS) containing the same information that would be required in a transfer statement for a broker-to-broker transaction. The Bill provides penalties for failure to comply with the broker-to-non-broker information reporting.

    REPORTING OF LARGE “CASH” TRANSACTIONS

    Code Section 6050I generally imposes reporting requirements upon any person who is engaged in a trade or business and, in the course of such trade or business, receives more than $10,000 in cash in one transaction or two or more related transactions. These transactions are reported on Form 8300, and the information required includes identifying information about the transferor and the transferee and a description of the transaction.

    The Bill expands the definition of “cash” for reporting purposes to include “any digital asset,” such that large transactions in tokens—including cryptocurrency—are required to be reported even outside the brokerage context.

    The Senate is expected to amend the Bill over the course of the coming weeks. Particularly, Senator Ron Wyden (D-OR), the chairman of the US Senate Committee on Finance, made a series of posts on Twitter prior to the release of the Bill. In the posts, Senator Wyden expressed concerns that the definition of “broker” lacked clarity and could encompass certain businesses that play an ancillary role in cryptocurrency trading, such as digital wallets and developers of blockchain technologies, and that imposing reporting requirements on such businesses could pose challenges and lead to unintended consequences. On August 3, 2021, Senator Wyden, along with Senators Cynthia Lummis (R-WY) and Patrick Toomey (R-PA), unveiled an amendment to the Bill which generally limits the definition of “broker” to entities with customers, clarifying that cryptocurrency miners, cryptocurrency hardware and software developers and digital asset developers are not intended to fall within the definition.

    Authors

    John T. Lutz

    Partner

    New York – One Vanderbilt Avenue

    More insights